Finalist
Successfully Launching Sandoz as the Independent Global Leader in Generic and Biosimilar Medicines
by Sandoz
Summary of work
2023 was an exceptional year for Sandoz, the global and European number one in generic and biosimilar medicines — which provide some 80% of medicines worldwide at just a quarter of the total cost. The USD 11.2bn Sandoz spin-off from Novartis in October was one of the most closely watched European business stories of 2023, making the company the biggest entrant on the Swiss stock market since 2019 and the largest European listing of 2023.
Successfully launching an independent Sandoz in DACH, the region in which it was founded, and around the world, required a fully integrated, carefully calibrated corporate communications campaign. From in-depth CEO interviews with key financial publications and the launch of the refreshed Sandoz brand and Sandoz.com website, to highly targeted social media campaigns and extensive internal communications, it’s a story that underlines the importance – and the direct impact – of communications excellence at a defining moment for a company and sector.
Judges’ comments
Sandoz has created a targeted and energetic campaign that produced some incredibly strong results. The team took something that could have been marginal and created a trusted and credible presence. The objectives were clear, the strategy was sophisticated, and the outcomes were significant.
